Zura Bio Limited
ZURA
$4.75
$0.000.00%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 7.46M | 7.57M | 9.36M | 8.78M | 6.49M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 18.41M | 19.52M | 18.06M | 19.25M | 15.73M |
| Operating Income | -18.41M | -19.52M | -18.06M | -19.25M | -15.73M |
| Income Before Tax | -17.18M | -18.04M | -15.99M | -17.44M | -13.63M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -17.18M | -18.04M | -15.99M | -17.44M | -13.63M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -17.18M | -18.04M | -15.99M | -17.44M | -13.63M |
| EBIT | -18.41M | -19.52M | -18.06M | -19.25M | -15.73M |
| EBITDA | -18.40M | -19.51M | -18.05M | -19.25M | -15.73M |
| EPS Basic | -0.48 | -0.21 | -0.17 | -0.19 | -0.10 |
| Normalized Basic EPS | -0.11 | -0.12 | -0.11 | -0.12 | -0.09 |
| EPS Diluted | -0.48 | -0.21 | -0.17 | -0.19 | -0.10 |
| Normalized Diluted EPS | -0.11 | -0.12 | -0.11 | -0.12 | -0.09 |
| Average Basic Shares Outstanding | 94.82M | 94.56M | 94.29M | 92.96M | 90.95M |
| Average Diluted Shares Outstanding | 94.82M | 94.56M | 94.29M | 92.96M | 90.95M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |